Skin lesion assessment and management model: optimising existing resources in the management of non-melanoma skin cancer

Author:

O'Hare Caitlin,McKeough Michael,Hickson Melanie,Ferris Rebekah,Wiper Jay,Wagels Michael

Abstract

Abstract Background Skin cancer is a relatively common cancer in Australia, with early, simple treatment conferring a high likelihood of cure. Early diagnosis and treatment are important to reduce morbidity and mortality. A see-and-treat clinic seeks to offer earlier diagnosis and treatment as compared with a traditional model of care. The aim was to implement this model using pre-existing infrastructure with a hypothesis that this service will reduce wait times with reduced costs and high levels of patient satisfaction    Methods Referrals were screened and those suitable underwent consultation with a Plastic and Reconstructive Surgeon and same-day operative management with their choice of anaesthesia. Patients were reviewed 1 week and 4 weeks postoperatively.   Results 206 patients had 286 skin lesions removed over 23 operating lists. Over 75% of excisions were on the face. Local anaesthetic with sedation was the most popular anaesthetic technique There were 22 complications and the incomplete excision rate was 4.2%. Average wait time for SLAM-suitable patients reduced by 76%, and category 1 outpatient waitlists were reduced by 100%. An estimated gross saving of $1,339 per patient was calculated. A survey of patients post-operatively showed all patients would recommend this model.   Conclusion This see-and-treat model was shown to reduce wait times and cost, along with high levels of patient satisfaction. It was also easily implemented using pre-existing infrastructure. It is a service that continues to be offered and expanded, with ongoing patient satisfaction.

Publisher

Australian Society of Plastic Surgeons

Reference15 articles.

1. Australian Institute of Health and Welfare 2016. Skin cancer in Australia, cat. no. can 96 [webreport]. Canberra: Australian Government [2016; cited 26/07/2020]. Available from: https://www.aihw.gov.au/getmedia/0368fb8b-10ef-4631-aa14-cb6d55043e4b/18197.pdf.aspx?inline=true.

2. Cancer Council Australia and The Australasian Council of Dermatologists. Skin cancer prevention: a blue chip investment in health. Sydney: Cancer Council Australia, 2009.

3. Cancer Council Australia and Australian Cancer Network. Basal cell carcinoma, squamous cell carcinoma (and related lesions): a guide to clinical management in Australia. Sydney: Cancer Council Australia, 2008.

4. Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197(10):565–68. https://doi.org/10.5694/mja12.10654. PMid:23163687

5. Australian Institute of Health and Welfare. Health system expenditure on cancer and other neoplasms in Australia: 2008–09. Cancer series no. 81. cat. no. can 78 [webreport]. Canberra: Australian Government [2013; cited 26/07/2020]. Available from: https://www.aihw.gov.au/getmedia/296395cc-f241-4c2f-a1a2-9e0b7c6a4d79/16199.pdf.aspx?inline=true.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3